Skip to content

Comparison of clinical outcome in dry eye treatment between corneal epithelial thickness assessment with spectral domain optical coherence tomography and clinical assessment

Comparison of clinical outcome in dry eye treatment between corneal epithelial thickness assessment with spectral domain optical coherence tomography and clinical assessment

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210706006
Enrollment
92
Registered
2021-07-06
Start date
2021-07-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal epithelial thickness measured by spectral domain optical coherence tomography can use for grading dry eye severity and have effect on treatment efficacy Corneal epithelial thickness, spectral domain optical coherence tomography, dry eye disease

Interventions

1.Optical coherence tomography group (Dry eye severity assessment by corneal epithelial thickness measurement) Corneal epithelial thickness variance less than 4 categorized as Mild to moderate dry
Experimental Device,No Intervention Other
Optical coherence tomography group,Control group

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Participant diagnosed Dry eye by TFOS DEWS II criteria - DEQ-5 Questionnaire not less than 6 with one of the followings - Non-invasive Tears film break up time < 10 second - Ocular surface staining at cornea >5 spot or conjunctiva > 9 spot or eyelid staining length not less than 2 mm and not less than 25 % width

Exclusion criteria

Exclusion criteria: -other ocular surface disease eg. Epithelial basement membrane dystrophy, Corneal scar, Herpes infection, Recurrent corneal erosion -eyelid or blinking problem -other ocular medication eg. glaucoma medication -contact lens wear -systemic medication eg.Anti-histamine, Estrogen replacement therapy, Anti-depressant, Isotretinoin -history of ocular trauma or ocular surgery

Design outcomes

Primary

MeasureTime frame
Eye dryness at 1 and 3 month after dry eye treatment Tear film break up time

Secondary

MeasureTime frame
Eye dryness at 1 and 3 month after dry eye treatment DEQ-5 score,Eye dryness at 1 and 3 month after dry eye treatment Corneal fluorescein stain grading

Countries

Thailand

Contacts

Public ContactPratan Piyasoonthorn

Chulabhorn hospital

pratan.piy@pccms.ac.th662576 6000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026